US Patent Issued to Global Cancer Technology on May 26 for "Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways" (California Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,450, issued on May 26, was assigned to Global Cancer Technology Inc. (San Diego). "Tri-substituted aryl and heteroaryl derivatives as modula... Read More

US Patent Issued to CHIESI FARMACEUTICI on May 26 for "Amino quinazoline derivatives as P2X 3 inhibitors" (Italian Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,451, issued on May 26, was assigned to CHIESI FARMACEUTICI S.P.A. (Parma, Italy). "Amino quinazoline derivatives as P2X 3 inhibitors" was in... Read More

US Patent Issued to GlaxoSmithKline Intellectual Property (No.3) on May 26 for "Crystalline forms of a substituted imidazopyridine compound and use thereof as P2X3 modulator" (Canadian Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,452, issued on May 26, was assigned to GlaxoSmithKline Intellectual Property (No.3) Ltd. (Stevenage, Great Britain). "Crystalline forms of a... Read More

US Patent Issued to Dana-Farber Cancer Institute on May 26 for "Pyrazolopyridine inhibitors of c-Jun-n-Terminal kinases and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,453, issued on May 26, was assigned to Dana-Farber Cancer Institute Inc. (Boston). "Pyrazolopyridine inhibitors of c-Jun-n-Terminal kinases ... Read More

US Patent Issued to Hoffmann-La Roche on May 26 for "Heterocyclic monoacylglycerol lipase (MAGL) inhibitors" (Swiss, German, French Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,454, issued on May 26, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Heterocyclic monoacylglycerol lipase (MAGL) inhibitors"... Read More

US Patent Issued to Richter Gedeon Nyrt. on May 26 for "Naphthyridine and pyrido[3,4-cpyridazine derivatives as GABA a Alpha5 receptor modulators" (Hungarian Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,455, issued on May 26, was assigned to Richter Gedeon Nyrt. (Budapest, Hungary). "Naphthyridine and pyrido[3,4-cpyridazine derivatives as GA... Read More

US Patent Issued to ADVERIO PHARMA on May 26 for "Process for preparing methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-bpyridin-3-ylpyrimidin-5-yl} carbamate" (German Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,456, issued on May 26, was assigned to ADVERIO PHARMA GMBH (Leverkusen, Germany). "Process for preparing methyl {4,6-diamino-2-[5-fluoro-1-(... Read More

US Patent Issued to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical on May 26 for "Salt form and crystal form of JAK inhibitor, preparation method therefor, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,457, issued on May 26, was assigned to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (Shanghai). "Salt form and crystal form of JAK ... Read More

US Patent Issued to IMPERIAL COLLEGE INNOVATIONS, MYRICX PHARMA on May 26 for "Imidazo[1,2-apyridine compounds and their use in therapy" (British, Swiss Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,458, issued on May 26, was assigned to IMPERIAL COLLEGE INNOVATIONS Ltd. (London) and MYRICX PHARMA Ltd. (London). "Imidazo[1,2-apyridine co... Read More

US Patent Issued to TAPI CZECH INDUSTRIES S.R.O on May 26 for "Solid state forms of Lorecivivint" (Czech Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,459, issued on May 26, was assigned to TAPI CZECH INDUSTRIES S.R.O (Opava-komarov, Czech Republic). "Solid state forms of Lorecivivint" was ... Read More

• ««
• «
• 60663
• 60664
• 60665
• 60666
• 60667
• 60668
• 60669
• 60670
• 60671
• 60672
• »
• »»